Skip to main content

Table 2 Operative findings and postoperative outcomes in PSM model

From: Modified duct-to-mucosa versus conventional pancreaticoenterostomy for pancreaticoduodenectomy: a retrospective cohort study based on propensity score matching analysis

Operative time (min)

Group A (n = 82)

Group B (n = 82)

P value

214.6 ± 28.5

229.8 ± 26.5

< 0.001

Pancreaticoenterostomy time (min)

9.3 ± 1.8

21.5 ± 2.8

< 0.001

Blood loss (ml)

314.4 ± 147.6

349.9 ± 132.4

0.107

Intra-operative blood transfusion (ml), n (%)

 None

44 (53.7)

27 (32.9)

0.025

 600

17 (20.7)

27 (32.9)

 > 600

21 (25.6)

28 (34.1)

Delayed gastric emptying, n (%)

4 (4.9)

9 (11.0)

0.148

ICU transfer, n (%)

4 (4.9)

6 (7.3)

0.514

Postoperative hospital stay (days)

15.1 ± 2.8

17.74 ± 4.9

0.008

Final diagnosis, n (%)

 Pancreatic cancer

42 (51.2)

33 (40.2)

0.158

 Bile duct cancer

7 (8.5)

7 (8.5)

> 0.999

 Intraductal papillary mucinous neoplasm

8 (9.8)

9 (11.0)

0.798

 Vater’s papilla cancer

5 (6.1)

4 (4.9)

0.732

 Neuroendocrine tumor

4 (4.9)

6 (7.3)

0.514

 Metastasis from other organs

6 (7.3)

5 (6.1)

0.755

 GIST

1 (1.2)

3 (3.7)

0.620

 Chronic pancreatitis

1 (1.2)

6 (7.3)

0.053

 Solid pseudopapillary tumor

6 (7.3)

6 (7.3)

> 0.999

 Duodenal cancer

2 (2.4)

3 (3.7)

0.650

  1. PSM propensity score matching